HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ohad Benjamini Selected Research

bisantrene

2/2021A phase II study of bisantrene in patients with relapsed/refractory acute myeloid leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ohad Benjamini Research Topics

Disease

9B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2022 - 11/2013
3Neoplasms (Cancer)
01/2022 - 06/2015
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
02/2021 - 06/2015
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
11/2020 - 06/2018
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2014 - 03/2014
1COVID-19
01/2022
1Hodgkin Disease (Hodgkin's Disease)
12/2021
1Cardiotoxicity
02/2021
1Aspergillosis
12/2019
1Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2019
1Mycoses (Diseases, Fungus)
12/2019
1Acute Promyelocytic Leukemia
06/2018
1Hematologic Neoplasms (Hematological Malignancy)
01/2016
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2016
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2016
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
06/2015
1Second Primary Neoplasms (Neoplasms, Second)
06/2015
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
03/2014
1Philadelphia Chromosome
03/2014
1Blast Crisis (Blast Phase)
03/2014
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
11/2013
1Splenomegaly
09/2012
1Primary Myelofibrosis (Myelosclerosis)
09/2012
1Pericarditis
06/2007
1Cardiomyopathies (Cardiomyopathy)
06/2007

Drug/Important Bio-Agent (IBA)

3COVID-19 VaccinesIBA
01/2022 - 01/2021
2Messenger RNA (mRNA)IBA
01/2022 - 01/2021
2ibrutinibIBA
12/2019 - 06/2014
1VaccinesIBA
01/2022
1mRNA VaccinesIBA
01/2022
1BNT162 VaccineIBA
01/2022
1Antineoplastic Agents (Antineoplastics)IBA
01/2022
1Brentuximab VedotinIBA
12/2021
1bisantreneIBA
02/2021
1anthraceneIBA
02/2021
1AnthracyclinesIBA
02/2021
1obinutuzumabIBA
01/2020
1Chlorambucil (Leukeran)FDA Link
01/2020
1Tretinoin (Retinoic Acid)FDA LinkGeneric
06/2018
1Arsenic Trioxide (Trisenox)FDA Link
06/2018
1Cyclin D1IBA
01/2016
1Small Interfering RNA (siRNA)IBA
01/2016
1Rituximab (Mabthera)FDA Link
06/2015
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2015
1fludarabineIBA
06/2015
1Tyrosine Kinase InhibitorsIBA
12/2014
1Bevacizumab (Avastin)FDA Link
11/2014
1Agammaglobulinaemia Tyrosine KinaseIBA
06/2014
1Dasatinib (BMS 354825)FDA Link
03/2014
1Therapeutic UsesIBA
09/2012
1ruxolitinibIBA
09/2012
1InterferonsIBA
06/2007

Therapy/Procedure

5Therapeutics
01/2022 - 06/2015
2Stem Cell Transplantation
12/2021 - 05/2015
1Drug Therapy (Chemotherapy)
12/2021
1Aftercare (After-Treatment)
06/2018
1Transplantation
05/2015
1Immunotherapy
11/2013